Expert Opinion on Drug Safety

Monitoring self-medication
pp. 1-5(5)
Author: Hughes C.M.

Safety and efficacy of meningococcal group C conjugate vaccines
pp. 7-19(13)
Authors: Rüggeberg J.; Heath P.T.

Neuroleptic malignant syndrome induced by atypical antipsychotics
pp. 21-35(15)
Author: Farver D.K.

Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension
pp. 37-47(11)
Author: Perazella M.A.

Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
pp. 49-58(10)
Authors: Westerhout C.M.; Boersma E.

Cardiotoxic effects of anthracycline–taxane combinations
pp. 59-71(13)
Authors: Perotti A.; Cresta S.; Grasselli G.; Capri G.; Minotti G.; Gianni L.

Safety issues surrounding the use of aromatase inhibitors in breast cancer
pp. 73-86(14)
Authors: Jackson J.; Miller W.; Dixon J.

Safety of low molecular weight heparins in the treatment of venous thromboembolism
pp. 87-94(8)
Authors: Bernardi E.; Prandoni P.

4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
pp. 95-101(7)
Authors: Nolan D.; Christiansen F.